Batt, Sarah L; Charalambous, Bambos M; Solomon, Anthony W; Knirsch, Charles; Massae, Patrick A; Safari, Salesia; Sam, Noel E; Everett, Dean; Mabey, David CW; Gillespie, Stephen H; (2003) Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 47 (9). pp. 2765-2769. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.47.9.2765-2769.2003 Full text not available from this repository.

Coast, Joanna; Smith, Richard D; (2003) Antimicrobial resistance: cost and containment. Expert review of anti-infective therapy, 1 (2). pp. 241-251. ISSN 1478-7210 DOI: https://doi.org/10.1586/14787210.1.2.241 Full text not available from this repository.

Coast, Joanna; Smith, Richard D; (2003) Solving the problem of antimicrobial resistance: is a global approach necessary? Drug discovery today, 8 (1). pp. 1-2. ISSN 1359-6446 DOI: https://doi.org/10.1016/s1359-6446(02)02542-4 Full text not available from this repository.

Croft, SL; (2003) Antiprotozoals. In: Finch, RG; Greenwood, D; Norrby, SR; Whitley, RJ, (eds.) Antibiotic and Chemotherapy. Churchill Livingstone, London, pp. 452-471. https://researchonline.lshtm.ac.uk/id/eprint/15630 Full text not available from this repository.

Croft, Simon L; Coombs, Graham H; (2003) Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. Trends in parasitology, 19 (11). pp. 502-508. ISSN 1471-4922 DOI: https://doi.org/10.1016/j.pt.2003.09.008 Full text not available from this repository.

Croft, Simon L; Seifert, Karin; Duchêne, Michael; (2003) Antiprotozoal activities of phospholipid analogues. Molecular and biochemical parasitology, 126 (2). pp. 165-172. ISSN 0166-6851 DOI: https://doi.org/10.1016/s0166-6851(02)00283-9 Full text not available from this repository.

Gupta, Rajesh; Espinal, Marcos; Stop TB Working Group on DOTS-Plus for MDR-TB; (2003) A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB). The international journal of tuberculosis and lung disease, 7 (5). pp. 410-414. ISSN 1027-3719 https://researchonline.lshtm.ac.uk/id/eprint/17595 Full text not available from this repository.

Hinchliffe, Stewart J; Isherwood, Karen E; Stabler, Richard A; Prentice, Michael B; Rakin, Alexander; Nichols, Richard A; Oyston, Petra CF; Hinds, Jason; Titball, Richard W; Wren, Brendan W; (2003) Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. Genome research, 13 (9). pp. 2018-2029. ISSN 1088-9051 DOI: https://doi.org/10.1101/gr.1507303 Full text not available from this repository.

Mortimer, D; Smith, RD; Coast, J; Millar, MR; Mills, A; (2003) Development of an economic model of antimicrobial resistance. Report to: Department of Child and Adolescent Health Development, World Health Organization. Technical Report. Department of Child and Adolescent Health Development, World Health Organization, Geneva. https://researchonline.lshtm.ac.uk/id/eprint/18910 Item availability may be restricted.

Pinheiro, L; Franco, S; Adagu, IS; Rosa, R; Rosário, VE; Warhurst, DC; (2003) [Presence of the double pfmdr1 mutation 86Tyr and 1246 Tyr in clones of a chloroquine-resistant west African isolate of Plasmodium falciparum]. Acta medica portuguesa, 16 (4). pp. 229-233. ISSN 0870-399X https://researchonline.lshtm.ac.uk/id/eprint/354889

Roper, Cally; Pearce, Richard; Bredenkamp, Barry; Gumede, Jonathan; Drakeley, Chris; Mosha, Frank; Chandramohan, Daniel; Sharp, Brian; (2003) Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet, 361 (9364). pp. 1174-1181. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(03)12951-0 Full text not available from this repository.

Seifert, Karin; Matu, Sangeeta; Javier Pérez-Victoria, F; Castanys, Santiago; Gamarro, Francisco; Croft, Simon L; (2003) Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International journal of antimicrobial agents, 22 (4). pp. 380-387. ISSN 0924-8579 DOI: https://doi.org/10.1016/s0924-8579(03)00125-0 Full text not available from this repository.

Smith, R; (2003) What does economics have to offer in the war against antimicrobial resistance? In: Knobler, SL; Lemon, SM; Burroughs, T, (eds.) Exploring the Challenges and Consequences of Resistances: Factors in Microbes, Vectors, and the Human Host. National Academy Press, Washington DC. https://researchonline.lshtm.ac.uk/id/eprint/19350 Full text not available from this repository.

Smith, R; Coast, J; (2003) Antimicrobial Drug resistance. In: Smith, RichardD; Beaglehole, R; Drager, N; Woodward, D, (eds.) Global Public Goods for Health: a health economic and public health perspective. OUP, Oxford. https://researchonline.lshtm.ac.uk/id/eprint/10117 Full text not available from this repository.

Smith, R; Coast, J; (2003) Resisting Resistance: thinking strategically about antimicrobial resistance. Georgetown Journal of International Affairs, IV (1). pp. 135-141. https://researchonline.lshtm.ac.uk/id/eprint/10120 Full text not available from this repository.

Warhurst, David C; (2003) Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malaria journal, 2 (1). 31-. ISSN 1475-2875 DOI: https://doi.org/10.1186/1475-2875-2-31

Warhurst, David C; Steele, Jonathan CP; Adagu, Ipemida S; Craig, John C; Cullander, Christopher; (2003) Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. The Journal of antimicrobial chemotherapy, 52 (2). pp. 188-193. ISSN 0305-7453 DOI: https://doi.org/10.1093/jac/dkg319 Full text not available from this repository.